Skip to main content

TRANSACT TECHNOLOGIES INC Value Stock - Dividend - Research Selection

Transact technologies

ISIN: US8929181035 , WKN: 910968

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

TransAct Technologies Incorporated designs, develops, assembles, and markets transaction-based and specialty printers and terminals in the United States and internationally. It offers thermal, inkjet, and impact printers and terminals to generate labels and transaction records, such as receipts, tickets, coupons, register journals, and other documents, as well as printed logging and plotting of data. The company also provides consumable products, including inkjet cartridges, ribbons, receipt papers, color thermal papers, food safety labels, and other printing supplies, as well as replacement parts; maintenance, repair, and testing services; and refurbished printers. In addition, it offers EPICENTRAL print system, a software solution that enables casino operators to create promotional coupons and marketing messages, and print them at the slot machine; and technical support services, as well as spare parts and accessories. Further, the company provides AccuDate terminals for the restaurant solutions market combine hardware and software in a device that includes an operating system, touchscreen, and one or two thermal print mechanisms. The company markets its products under the AccuDate, Epic, EPICENTRAL, Ithaca, Responder, and Printrex brand names for restaurant, point of sale automation and banking, casino and gaming, lottery, mobile, oil and gas, and hospitality markets, as well as government. It sells its products to original equipment manufacturers, value-added resellers, and distributors, as well as directly and online to end-users. TransAct Technologies Incorporated was founded in 1996 and is headquartered in Hamden, Connecticut.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


TransAct Technologies Incorporated (TACT) Is Attractively Priced Despite Fast-paced Momentum

2023-11-20
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, TransAct Technologies Incorporated (TACT) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

3 Disruptive Stocks That Could Turn $500 into $5,000

2023-11-20
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

A Look At The Intrinsic Value Of TransAct Technologies Incorporated (NASDAQ:TACT)

2023-11-13
Key Insights The projected fair value for TransAct Technologies is US$7.83 based on 2 Stage Free Cash Flow to Equity...

TransAct Technologies Incorporated (NASDAQ:TACT) Q3 2023 Earnings Call Transcript

2023-11-11
TransAct Technologies Incorporated (NASDAQ:TACT) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Greetings, and welcome to the TransAct Technologies’ Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ryan Gardella, Investor Relations. Thank you, sir. You may begin. Ryan […]

TransAct Technologies Incorporated (TACT) Q3 2023 Earnings Call Transcript

2023-11-10
TransAct Technologies Incorporated (NASDAQ:NASDAQ:TACT) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ETCompany ParticipantsRyan Gardella –...

Transact Technologies: A Promising Investment Opportunity Foreseeing Substantial FST Ramp and Financial Growth in 2024-2025

2023-11-10
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Craig-Hallum Sticks to Its Buy Rating for Transact Technologies (TACT)

2023-11-10
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

TransAct Technologies Reports Preliminary Third Quarter 2023 Financial Results

2023-11-09
HAMDEN, Conn., November 09, 2023--TransAct Technologies Incorporated (Nasdaq: TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary results for the third quarter ended September 30, 2023.

Earnings Scheduled For November 9, 2023

2023-11-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

TransAct Tech Non-GAAP EPS of $0.09, revenue of $17.2M beats by $1.01M

2023-11-09
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.